lncRNA CERS6‐AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR‐125a‐5p to upregulate BAP1 expression
Long noncoding RNAs (lncRNAs) can act as oncogene and tumor suppressor genes in many types of cancers including breast cancer (BC). Our previous study has indicated microRNA (miR)‐125a‐5p was downregulated and function as a tumor suppressor in BC. However, its upstream regulation mechanism is still...
Saved in:
Published in | Molecular carcinogenesis Vol. 59; no. 10; pp. 1199 - 1208 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.10.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Long noncoding RNAs (lncRNAs) can act as oncogene and tumor suppressor genes in many types of cancers including breast cancer (BC). Our previous study has indicated microRNA (miR)‐125a‐5p was downregulated and function as a tumor suppressor in BC. However, its upstream regulation mechanism is still unclear. In this study, we used bioinformatics algorithms, RNA pulldown assay, and dual‐luciferase reports assay to predict and confirm lncRNA CERS6‐AS1 interacted with miR‐125a‐5p. Then we found CERS6‐AS1 was upregulated in BC tissues. Experimental results of tumor growth in nude mice show that CERS6‐AS1 promotes tumor growth. Furthermore, CERS6‐AS1 regulated BC susceptibility gene 1‐associated protein 1 (BAP1) expression via sponging miR‐125a‐5p via Western blot analysis and quantitative polymerase chain reaction arrays. Finally, we showed that miR‐125a‐5p had opposing effects to those of CERS6‐AS1 on BC cells, demonstrating that CERS6‐AS1 may promote cell proliferation and inhibit cell apoptosis via sponging miR‐125a‐5p. Our results indicated CERS6‐AS1 promote BC cell proliferation and inhibit cell apoptosis via sponging miR‐125a‐5p to upregulate BAP1 expression. |
---|---|
AbstractList | Long noncoding RNAs (lncRNAs) can act as oncogene and tumor suppressor genes in many types of cancers including breast cancer (BC). Our previous study has indicated microRNA (miR)-125a-5p was downregulated and function as a tumor suppressor in BC. However, its upstream regulation mechanism is still unclear. In this study, we used bioinformatics algorithms, RNA pulldown assay, and dual-luciferase reports assay to predict and confirm lncRNA CERS6-AS1 interacted with miR-125a-5p. Then we found CERS6-AS1 was upregulated in BC tissues. Experimental results of tumor growth in nude mice show that CERS6-AS1 promotes tumor growth. Furthermore, CERS6-AS1 regulated BC susceptibility gene 1-associated protein 1 (BAP1) expression via sponging miR-125a-5p via Western blot analysis and quantitative polymerase chain reaction arrays. Finally, we showed that miR-125a-5p had opposing effects to those of CERS6-AS1 on BC cells, demonstrating that CERS6-AS1 may promote cell proliferation and inhibit cell apoptosis via sponging miR-125a-5p. Our results indicated CERS6-AS1 promote BC cell proliferation and inhibit cell apoptosis via sponging miR-125a-5p to upregulate BAP1 expression.Long noncoding RNAs (lncRNAs) can act as oncogene and tumor suppressor genes in many types of cancers including breast cancer (BC). Our previous study has indicated microRNA (miR)-125a-5p was downregulated and function as a tumor suppressor in BC. However, its upstream regulation mechanism is still unclear. In this study, we used bioinformatics algorithms, RNA pulldown assay, and dual-luciferase reports assay to predict and confirm lncRNA CERS6-AS1 interacted with miR-125a-5p. Then we found CERS6-AS1 was upregulated in BC tissues. Experimental results of tumor growth in nude mice show that CERS6-AS1 promotes tumor growth. Furthermore, CERS6-AS1 regulated BC susceptibility gene 1-associated protein 1 (BAP1) expression via sponging miR-125a-5p via Western blot analysis and quantitative polymerase chain reaction arrays. Finally, we showed that miR-125a-5p had opposing effects to those of CERS6-AS1 on BC cells, demonstrating that CERS6-AS1 may promote cell proliferation and inhibit cell apoptosis via sponging miR-125a-5p. Our results indicated CERS6-AS1 promote BC cell proliferation and inhibit cell apoptosis via sponging miR-125a-5p to upregulate BAP1 expression. Long noncoding RNAs (lncRNAs) can act as oncogene and tumor suppressor genes in many types of cancers including breast cancer (BC). Our previous study has indicated microRNA (miR)‐125a‐5p was downregulated and function as a tumor suppressor in BC. However, its upstream regulation mechanism is still unclear. In this study, we used bioinformatics algorithms, RNA pulldown assay, and dual‐luciferase reports assay to predict and confirm lncRNA CERS6‐AS1 interacted with miR‐125a‐5p. Then we found CERS6‐AS1 was upregulated in BC tissues. Experimental results of tumor growth in nude mice show that CERS6‐AS1 promotes tumor growth. Furthermore, CERS6‐AS1 regulated BC susceptibility gene 1‐associated protein 1 (BAP1) expression via sponging miR‐125a‐5p via Western blot analysis and quantitative polymerase chain reaction arrays. Finally, we showed that miR‐125a‐5p had opposing effects to those of CERS6‐AS1 on BC cells, demonstrating that CERS6‐AS1 may promote cell proliferation and inhibit cell apoptosis via sponging miR‐125a‐5p. Our results indicated CERS6‐AS1 promote BC cell proliferation and inhibit cell apoptosis via sponging miR‐125a‐5p to upregulate BAP1 expression. |
Author | Li, Kai Ma, Jinzhu Feng, Zunyong Liu, Haijun Jiang, Yuxin Zhang, Jieling Wu, Xu Yan, Liang Zhu, Yiping Zhang, Yizongheng Zhang, Yao Han, Renrui |
Author_xml | – sequence: 1 givenname: Liang orcidid: 0000-0001-9066-8693 surname: Yan fullname: Yan, Liang organization: Wannan Medical College – sequence: 2 givenname: Kai surname: Li fullname: Li, Kai organization: The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College) – sequence: 3 givenname: Zunyong surname: Feng fullname: Feng, Zunyong organization: Wannan Medical College – sequence: 4 givenname: Yizongheng surname: Zhang fullname: Zhang, Yizongheng organization: Southern Medical University – sequence: 5 givenname: Renrui surname: Han fullname: Han, Renrui organization: Wannan Medical College – sequence: 6 givenname: Jinzhu surname: Ma fullname: Ma, Jinzhu organization: Wannan Medical College – sequence: 7 givenname: Jieling surname: Zhang fullname: Zhang, Jieling organization: The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College) – sequence: 8 givenname: Xu surname: Wu fullname: Wu, Xu organization: Wannan Medical College – sequence: 9 givenname: Haijun surname: Liu fullname: Liu, Haijun organization: Wannan Medical College – sequence: 10 givenname: Yuxin orcidid: 0000-0002-1133-495X surname: Jiang fullname: Jiang, Yuxin email: jiangyx@wnmc.edu.cn organization: Wannan Medical College – sequence: 11 givenname: Yao surname: Zhang fullname: Zhang, Yao email: yaozhang@ahedu.gov.cn organization: Wannan Medical College – sequence: 12 givenname: Yiping surname: Zhu fullname: Zhu, Yiping email: zhuyiping@wnmc.edu.cn organization: The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32808708$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kdtu1DAQhi1URLcFiSdAlrjhJsv4lNiXy6ocpHLQFq4jx3FWrhI72Ilg7-ANeEaeBKdbQKrg6teMvvntf-YMnfjgLUKPCawJAH0-mDVllKt7aEVAyYJWnJ-gFUilCqJkdYrOUroGIKQS8ACdMipBViBX6Hvvze7dBm8vdlflz28_NlcE64SNXZpjDEOYbK76fil619moJxc8Dh1uotVpwkZ7YyNuDjiNwe-d3-PB7bIVoUJnESOeAp7HaPdzr7Pbi80Hgu3X3EgpWz1E9zvdJ_voVs_Rp5cXH7evi8v3r95sN5eFYTzHEJRrA8SYqmOkkiBa25oma6PLBlqtKsV4SWxDrSRlyRiwlmkqFC-Bl5Sxc_Ts6JuDfJ5tmurBpSWZ9jbMqaacCSIl5ZDRp3fQ6zBHn3-3UKoEIUBk6sktNTeDbesxukHHQ_17uX9fNDGkFG33ByFQL3erB1Pf3C2j6zuocdPNpqeoXf-vgeI48MX19vBf4_rt9sj_Ak9KptM |
CitedBy_id | crossref_primary_10_1111_1759_7714_15035 crossref_primary_10_1186_s12957_021_02166_w crossref_primary_10_1016_j_prp_2022_154245 crossref_primary_10_1080_21655979_2022_2059982 crossref_primary_10_1002_kjm2_12503 crossref_primary_10_1080_21655979_2021_2012620 crossref_primary_10_1002_jbt_23037 crossref_primary_10_1186_s12935_023_03121_3 crossref_primary_10_1016_j_scitotenv_2024_173041 crossref_primary_10_1097_CAD_0000000000001381 crossref_primary_10_3390_ijms24032107 crossref_primary_10_3724_abbs_2023226 crossref_primary_10_1155_2022_9292538 crossref_primary_10_2147_OTT_S278582 crossref_primary_10_1038_s41420_022_01150_x crossref_primary_10_1038_s41375_024_02344_1 crossref_primary_10_1002_mc_23529 crossref_primary_10_1097_MPA_0000000000001806 crossref_primary_10_1038_s41419_021_03921_3 crossref_primary_10_1002_mc_23569 crossref_primary_10_1016_j_ncrna_2023_11_013 crossref_primary_10_2174_0929867329666220614091445 crossref_primary_10_1186_s12890_022_02272_9 |
Cites_doi | 10.3390/ijms20153616 10.1093/nar/gkv1353 10.7150/ijbs.27197 10.1038/s41419-018-1170-0 10.1016/j.cell.2015.02.053 10.1007/s13258-019-00866-y 10.1371/journal.pone.0040169 10.1007/978-3-030-20301-6_4 10.3322/caac.21442 10.1158/0008-5472.CAN-16-0356 10.15252/embj.2018101110 10.1038/s41588-018-0252-3 10.1038/ncomms6383 10.1615/CritRevEukaryotGeneExpr.2017019494 10.1155/2015/439370 10.1136/jmg.2008.063123 10.1016/j.molcel.2017.09.015 10.1002/jcb.27124 10.1038/nature12986 10.2174/1871520616666160502122724 10.1098/rsob.160181 10.3389/fgene.2014.00249 10.1093/abbs/gmx047 10.1038/s41434-018-0026-7 10.1186/s12890-020-01180-0 10.1593/neo.09942 10.1038/nrg.2015.10 10.1186/s12943-017-0735-3 10.3322/caac.21492 10.1016/j.abb.2018.03.018 10.1038/onc.2017.184 10.1002/iub.2325 |
ContentType | Journal Article |
Copyright | 2020 Wiley Periodicals LLC 2020 Wiley Periodicals LLC. |
Copyright_xml | – notice: 2020 Wiley Periodicals LLC – notice: 2020 Wiley Periodicals LLC. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TM 7TO 8FD FR3 H94 P64 RC3 7X8 |
DOI | 10.1002/mc.23249 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Nucleic Acids Abstracts AIDS and Cancer Research Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef Genetics Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1098-2744 |
EndPage | 1208 |
ExternalDocumentID | 32808708 10_1002_mc_23249 MC23249 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Key Research Foundation of Wannan Medical College funderid: WK2019Z7 – fundername: Foundation of “Peak” Training Program for Scientific Research of Yijishan Hospital, Wannan Medical College funderid: GF2019G11 – fundername: Foundation for the Cultivation of Outstanding and Top Talents in Colleges and Universities of Anhui Province funderid: gxgnfx2019010 – fundername: National Natural Science Foundation of China funderid: 81802651; 81671586 |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEFU ABEML ABIJN ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GLUZI GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IH2 IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6P MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TUS UB1 V2E V8K W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WWO WXI WXSBR XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7TM 7TO 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY FR3 H94 P64 RC3 7X8 |
ID | FETCH-LOGICAL-c3499-524ac01cc7f317805dedcb805ba6b0da9793461eb2e81663303d3a25946046233 |
IEDL.DBID | DR2 |
ISSN | 0899-1987 1098-2744 |
IngestDate | Fri Jul 11 00:40:01 EDT 2025 Fri Jul 25 06:37:11 EDT 2025 Wed Feb 19 02:23:19 EST 2025 Thu Apr 24 23:00:37 EDT 2025 Tue Jul 01 00:38:47 EDT 2025 Wed Jan 22 16:34:36 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | breast cancer lncRNA CERS6-AS1 miR-125a-5p |
Language | English |
License | 2020 Wiley Periodicals LLC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3499-524ac01cc7f317805dedcb805ba6b0da9793461eb2e81663303d3a25946046233 |
Notes | Liang Yan, Kai Li, and Zunyong Fen contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-1133-495X 0000-0001-9066-8693 |
PMID | 32808708 |
PQID | 2439605505 |
PQPubID | 105347 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2435188240 proquest_journals_2439605505 pubmed_primary_32808708 crossref_primary_10_1002_mc_23249 crossref_citationtrail_10_1002_mc_23249 wiley_primary_10_1002_mc_23249_MC23249 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | October 2020 2020-10-00 20201001 |
PublicationDateYYYYMMDD | 2020-10-01 |
PublicationDate_xml | – month: 10 year: 2020 text: October 2020 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Austin |
PublicationTitle | Molecular carcinogenesis |
PublicationTitleAlternate | Mol Carcinog |
PublicationYear | 2020 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2015; 161 2009; 46 2018; 645 2020; 20 2017; 27 2017; 49 2017; 68 2016; 76 2019; 38 2016; 17 2018; 22 2018; 25 2018; 68 2009; 11 2016; 6 2018; 9 2014; 5 2014; 505 2019; 20 2019; 41 2017; 36 2017; 17 2018; 119 2020; 72 2017; 16 2015; 2015 2018; 50 2019; 1152 2012; 7 2018; 14 2016; 44 e_1_2_10_23_1 e_1_2_10_24_1 e_1_2_10_21_1 e_1_2_10_22_1 e_1_2_10_20_1 e_1_2_10_2_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_3_1 Hu HB (e_1_2_10_15_1) 2018; 22 e_1_2_10_19_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_7_1 e_1_2_10_12_1 e_1_2_10_9_1 e_1_2_10_13_1 e_1_2_10_34_1 e_1_2_10_10_1 e_1_2_10_33_1 e_1_2_10_11_1 e_1_2_10_32_1 e_1_2_10_31_1 e_1_2_10_30_1 e_1_2_10_29_1 e_1_2_10_27_1 e_1_2_10_28_1 e_1_2_10_25_1 e_1_2_10_26_1 37232354 - Mol Carcinog. 2023 May 26 |
References_xml | – volume: 20 start-page: 153 issue: 1 year: 2020 article-title: LncRNA WTAPP1 promotes cancer cell invasion and migration in NSCLC by downregulating lncRNA HAND2‐AS1 publication-title: BMC Pulm Med – volume: 41 start-page: 1431 issue: 12 year: 2019 end-page: 1443 article-title: A thiosemicarbazone derivative induces triple negative breast cancer cell apoptosis: possible role of miRNA‐125a‐5p and miRNA‐181a‐5p publication-title: Genes Genomics. – volume: 1152 start-page: 51 year: 2019 end-page: 64 article-title: Breast cancer: current perspectives on the disease status publication-title: Adv Exp Med Biol – volume: 44 start-page: 3059 issue: 7 year: 2016 end-page: 3069 article-title: Linc‐RoR promotes c‐Myc expression through hnRNP I and AUF1 publication-title: Nucleic Acids Res – volume: 9 start-page: 1158 issue: 12 year: 2018 article-title: LncRNA UCA1 promotes tumor metastasis by inducing miR‐203/ZEB2 axis in gastric cancer publication-title: Cell Death Dis – volume: 5 start-page: 249 year: 2014 article-title: HumanViCe: host ceRNA network in virus infected cells in human publication-title: Front Genet – volume: 50 start-page: 1705 issue: 12 year: 2018 end-page: 1715 article-title: Long noncoding RNA MALAT1 suppresses breast cancer metastasis publication-title: Nat Genet – volume: 22 start-page: 1987 issue: 7 year: 2018 end-page: 1993 article-title: LncRNA LINC01116 competes with miR‐145 for the regulation of ESR1 expression in breast cancer publication-title: Eur Rev Med Pharmacol Sci – volume: 68 start-page: 394 issue: 6 year: 2018 end-page: 424 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin – volume: 68 start-page: 171 issue: 1 year: 2017 end-page: 184.e6 article-title: A peptide encoded by a putative lncRNA HOXB‐AS3 suppresses colon cancer growth publication-title: Mol Cell – volume: 68 start-page: 7 issue: 1 year: 2018 end-page: 30 article-title: Cancer statistics, 2018 publication-title: CA Cancer J Clin – volume: 17 start-page: 47 issue: 1 year: 2016 end-page: 62 article-title: Unique features of long non‐coding RNA biogenesis and function publication-title: Nat Rev Genet – volume: 25 start-page: 321 issue: 5 year: 2018 end-page: 330 article-title: LncRNA FTX sponges miR‐215 and inhibits phosphorylation of vimentin for promoting colorectal cancer progression publication-title: Gene Ther – volume: 5 start-page: 5383 year: 2014 article-title: The oestrogen receptor alpha‐regulated lncRNA NEAT1 is a critical modulator of prostate cancer publication-title: Nat Commun – volume: 17 start-page: 152 issue: 2 year: 2017 end-page: 163 article-title: Breast cancer: current molecular therapeutic targets and new players publication-title: Anticancer Agents Med Chem – volume: 119 start-page: 8773 issue: 11 year: 2018 end-page: 8783 article-title: MiR‐125a‐5p functions as a tumour suppressor in breast cancer by downregulating BAP1 publication-title: J Cell Biochem – volume: 14 start-page: 1715 issue: 12 year: 2018 end-page: 1723 article-title: TGF‐beta/SMAD4‐regulated LncRNA‐LINP1 inhibits epithelial‐mesenchymal transition in lung cancer publication-title: Int J Biol Sci – volume: 161 start-page: 790 issue: 4 year: 2015 end-page: 802 article-title: Endogenous tRNA‐derived fragments suppress breast cancer progression via YBX1 displacement publication-title: Cell – volume: 36 start-page: 5661 issue: 41 year: 2017 end-page: 5667 article-title: LncRNA‐mediated regulation of cell signaling in cancer publication-title: Oncogene – volume: 46 start-page: 358 issue: 5 year: 2009 end-page: 360 article-title: Germline mutation of microRNA‐125a is associated with breast cancer publication-title: J Med Genet – volume: 76 start-page: 6299 issue: 21 year: 2016 end-page: 6310 article-title: LncRNA HOXA11‐AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1 publication-title: Cancer Res – volume: 11 start-page: 1208 issue: 11 year: 2009 end-page: 1215 article-title: The epidermal growth factor receptor responsive miR‐125a represses mesenchymal morphology in ovarian cancer cells publication-title: Neoplasia – volume: 2015 year: 2015 article-title: Anaplastic thyroid carcinoma: a ceRNA analysis pointed to a crosstalk between SOX2, TP53, and microRNA biogenesis publication-title: Int J Endocrinol – volume: 49 start-page: 588 issue: 7 year: 2017 end-page: 597 article-title: LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR‐145 publication-title: Acta Biochim Biophys Sin – volume: 38 issue: 17 year: 2019 article-title: LncRNA HAND2‐AS1 promotes liver cancer stem cell self‐renewal via BMP signaling publication-title: EMBO J – volume: 72 start-page: 1856 issue: 9 year: 2020 end-page: 1869 article-title: Role of microRNAs in infection: potential biomarkers and mechanism [published online ahead of print June 09, 2020] publication-title: IUBMB Life – volume: 16 start-page: 166 issue: 1 year: 2017 article-title: LncRNA RP11‐436H11.5, functioning as a competitive endogenous RNA, upregulates BCL‐W expression by sponging miR‐335‐5p and promotes proliferation and invasion in renal cell carcinoma publication-title: Mol Cancer – volume: 20 start-page: 3616 issue: 15 year: 2019 article-title: LncRNA NEAT1 silenced miR‐133b promotes migration and invasion of breast cancer cells publication-title: Int J Mol Sci – volume: 6 issue: 11 year: 2016 article-title: The miR‐125 family is an important regulator of the expression and maintenance of maternal effect genes during preimplantational embryo development publication-title: Open Biol – volume: 27 start-page: 197 issue: 3 year: 2017 end-page: 204 article-title: miRNA: a diagnostic and therapeutic tool for pancreatic cancer publication-title: Crit Rev Eukaryot Gene Expr – volume: 645 start-page: 117 year: 2018 end-page: 125 article-title: Long non‐coding RNA ROR promotes radioresistance in hepatocelluar carcinoma cells by acting as a ceRNA for microRNA‐145 to regulate RAD18 expression publication-title: Arch Biochem Biophys – volume: 505 start-page: 344 issue: 7483 year: 2014 end-page: 352 article-title: The multilayered complexity of ceRNA crosstalk and competition publication-title: Nature – volume: 7 issue: 6 year: 2012 article-title: Ectopic expression of MiR‐125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF publication-title: PLoS One – ident: e_1_2_10_16_1 doi: 10.3390/ijms20153616 – ident: e_1_2_10_29_1 doi: 10.1093/nar/gkv1353 – ident: e_1_2_10_30_1 doi: 10.7150/ijbs.27197 – ident: e_1_2_10_34_1 doi: 10.1038/s41419-018-1170-0 – ident: e_1_2_10_21_1 doi: 10.1016/j.cell.2015.02.053 – ident: e_1_2_10_8_1 doi: 10.1007/s13258-019-00866-y – ident: e_1_2_10_23_1 doi: 10.1371/journal.pone.0040169 – ident: e_1_2_10_3_1 doi: 10.1007/978-3-030-20301-6_4 – ident: e_1_2_10_4_1 doi: 10.3322/caac.21442 – ident: e_1_2_10_19_1 doi: 10.1158/0008-5472.CAN-16-0356 – ident: e_1_2_10_28_1 doi: 10.15252/embj.2018101110 – ident: e_1_2_10_14_1 doi: 10.1038/s41588-018-0252-3 – volume: 22 start-page: 1987 issue: 7 year: 2018 ident: e_1_2_10_15_1 article-title: LncRNA LINC01116 competes with miR‐145 for the regulation of ESR1 expression in breast cancer publication-title: Eur Rev Med Pharmacol Sci – ident: e_1_2_10_26_1 doi: 10.1038/ncomms6383 – ident: e_1_2_10_6_1 doi: 10.1615/CritRevEukaryotGeneExpr.2017019494 – ident: e_1_2_10_11_1 doi: 10.1155/2015/439370 – ident: e_1_2_10_25_1 doi: 10.1136/jmg.2008.063123 – ident: e_1_2_10_20_1 doi: 10.1016/j.molcel.2017.09.015 – ident: e_1_2_10_9_1 doi: 10.1002/jcb.27124 – ident: e_1_2_10_31_1 doi: 10.1038/nature12986 – ident: e_1_2_10_5_1 doi: 10.2174/1871520616666160502122724 – ident: e_1_2_10_22_1 doi: 10.1098/rsob.160181 – ident: e_1_2_10_10_1 doi: 10.3389/fgene.2014.00249 – ident: e_1_2_10_32_1 doi: 10.1093/abbs/gmx047 – ident: e_1_2_10_33_1 doi: 10.1038/s41434-018-0026-7 – ident: e_1_2_10_27_1 doi: 10.1186/s12890-020-01180-0 – ident: e_1_2_10_24_1 doi: 10.1593/neo.09942 – ident: e_1_2_10_12_1 doi: 10.1038/nrg.2015.10 – ident: e_1_2_10_18_1 doi: 10.1186/s12943-017-0735-3 – ident: e_1_2_10_2_1 doi: 10.3322/caac.21492 – ident: e_1_2_10_17_1 doi: 10.1016/j.abb.2018.03.018 – ident: e_1_2_10_13_1 doi: 10.1038/onc.2017.184 – ident: e_1_2_10_7_1 doi: 10.1002/iub.2325 – reference: 37232354 - Mol Carcinog. 2023 May 26;: |
SSID | ssj0011750 |
Score | 2.414729 |
Snippet | Long noncoding RNAs (lncRNAs) can act as oncogene and tumor suppressor genes in many types of cancers including breast cancer (BC). Our previous study has... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1199 |
SubjectTerms | Animals Apoptosis Bioinformatics Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism Breast cancer Breast Neoplasms - genetics Breast Neoplasms - metabolism Breast Neoplasms - pathology Cell growth Cell Proliferation Female Gene Expression Regulation, Neoplastic Humans lncRNA CERS6‐AS1 Membrane Proteins - antagonists & inhibitors Membrane Proteins - genetics Mice Mice, Nude MicroRNAs - genetics miRNA miR‐125a‐5p Oligonucleotides, Antisense - genetics Polymerase chain reaction RNA, Long Noncoding - genetics Sphingosine N-Acyltransferase - antagonists & inhibitors Sphingosine N-Acyltransferase - genetics Tumor Cells, Cultured Tumor suppressor genes Tumor Suppressor Proteins - genetics Tumor Suppressor Proteins - metabolism Ubiquitin Thiolesterase - genetics Ubiquitin Thiolesterase - metabolism Xenograft Model Antitumor Assays |
Title | lncRNA CERS6‐AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR‐125a‐5p to upregulate BAP1 expression |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmc.23249 https://www.ncbi.nlm.nih.gov/pubmed/32808708 https://www.proquest.com/docview/2439605505 https://www.proquest.com/docview/2435188240 |
Volume | 59 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bSsNAEB1EUHzxfqk3VhB9St1m0zR9rEURoSJVQfAh7G62IrZpaVNQn_QP_Ea_xJnNRbyB-LSk3SbNZmb3zObMGYDdyBDuoIweXOwc9ETjSOMJxzMCwUbUQTuifOfWmX9y5Z1eV68zViXlwqT6EMWGG3mGna_JwaUaHXyIhvZ0mdAA5e4RVYvwULtQjiIBSru9guGEQ3F1rjvL3YP8h59Xom_w8jNatcvN8Rzc5H80ZZncl8eJKuunLxqO_7uTeZjNUChrpGazABMmXoSptC7l4yJMt7I37kvw0o11-6zBmkftC__t-bVxUWFyxLShDweWy2cY7f7TQZd4MvZRs36HKeK7J0yTXQ2ZemTExqWaSKx318ZTIeiR2FQHLOmz8WBobqmUmGGHjfMKMw8ZQzdehqvjo8vmiZOVbXC0wPgJQ1tPal7RutZBcBLwamQirbBV0lc8knWcEjy_giG9oZeWAhfRSEgMwzyfMmWFWIHJuB-bNWB1X7l-UMOxQcPhdS69qN7xFJeBEjUpeQn280cY6kzTnEprdMNUjdkNezq0Y1uCnaLnINXx-KHPZm4FYebJo9BFxIYhHwJFPEXxNfogDa2MTX9s-5CuHYKjEqym1lNcRLgBxzkxKMGetYFfrx62mrZd_2vHDZhxKfi3zMJNmEyGY7OFCClR29YX3gHhjgmf |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fT9swED8x0ICXwRhsZTA8adqeUtw4TRPxVAqobLSaCkg8IEW24yJEm1YllYCn7RvsM_JJduf8QWxDQnuykjh2Yt_Zv7PPvwP4FBvCHXSiByc7BzXRONJ4wvGMQLAR91GO6Lxzp-u3T72vZ_WzGdgpzsJk_BDlghtphh2vScFpQXr7gTV0qKsEB8IXMEcBvYk4f69XckcRBaVdYEGDwiHLumCe5e528ebjuegvgPkYr9oJ52AJzotPzfxMrqrTVFX13R8sjv_5L8vwKgeirJlJzmuYMckKvMxCU96uwHwn33R_Az8Hie51m6y13zv273_8ah7XmLxm2tDNsXXnM4w2AOhiQK4ytrfZqM8UubynTJNoTZi6ZeSQS2GR2PCyh0Uh7pGY1McsHbHpeGIuKJqYYbvN7zVmbnIn3WQVTg_2T1ptJ4_c4GiBJhRat57UvKZ1o4_4JOD12MRaYaqkr3gsQxwVPL-GVr2hfUuB82gsJFpink-HZYVYg9lklJh3wEJfuX7QwLZB2eEhl14c9j3FZaBEQ0pegS9FH0Y6pzWn6BqDKCNkdqOhjmzbVuBjmXOcUXn8I89GIQZRrszXkYugDa0-xIpYRPkY1ZCaViZmNLV5iNoO8VEF3mbiU1Yi3IDjsBhU4LMVgidrjzotm64_N-MWLLRPOkfR0WH323tYdGktwDoabsBsOpmaTQRMqfpgFeM3dzQNuw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bT9swFD5ioCFeYOOydbDNSNP2lJImbpo8ltKKAa1QAQlpD5HtOBNam0YllWBP8A_4jfwSznEuU3eR0J6sJI6d2OfY37GPvwPwKdKEO-hED052FmqitoTmrsW1i2AjilGO6Lxzf-AdXvCjy-Zl4VVJZ2FyfohqwY00w4zXpOBpFO_9Ig0dqzqhgeAFLHHPDihsw8Gwoo4iBkqzvoL2hEWGdUk8azt75ZvzU9Ef-HIerpr5prcG38ovzd1MftRnmayrn7-ROP7fr7yC1QKGsnYuN69hQSfr8DIPTHm7Dsv9Yst9A-5HiRoO2qzTHZ55j3cP7bMGE9dMabqZGmc-zWj5ny5G5Chj-ppNYibJ4T1jigRryuQtI3dcCorExldDLApRj8CkmbJswmbpVH-nWGKa7bdPG0zfFC66ySZc9LrnnUOriNtgKRcNKLRtuVB2Q6lWjOjEt5uRjpTEVApP2pEIcEzgXgNtek27li7OopEr0A7DfuQIx9wtWEwmiX4LLPCk4_ktbBuUHOxkwaMg5tIWvnRbQtg1-FJ2YagKUnOKrTEKczpmJxyr0LRtDXarnGlO5PGXPDulFISFKl-HDkI2tPkQKWIR1WNUQmpakejJzOQhYjtERzV4k0tPVYnr-DYOin4NPhsZ-GftYb9j0nfPzfgRlk8PeuHJ18HxNqw4tBBgvAx3YDGbzvR7REuZ_GDU4glBYQxq |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=lncRNA+CERS6-AS1+as+ceRNA+promote+cell+proliferation+of+breast+cancer+by+sponging+miR-125a-5p+to+upregulate+BAP1+expression&rft.jtitle=Molecular+carcinogenesis&rft.au=Yan%2C+Liang&rft.au=Li%2C+Kai&rft.au=Feng%2C+Zunyong&rft.au=Zhang%2C+Yizongheng&rft.date=2020-10-01&rft.issn=1098-2744&rft.eissn=1098-2744&rft.volume=59&rft.issue=10&rft.spage=1199&rft_id=info:doi/10.1002%2Fmc.23249&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0899-1987&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0899-1987&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0899-1987&client=summon |